Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001498428-25-000003

CEO & President sold 2,640 shares at $13.41 ($35,402)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Cox John · CEO & President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-09-05 Sale : show line 1 in the form 10b5-1 −2,640 $13.41 $35,402 199,539 D
Open-market sales · 2,640 sh · avg $13.41 · $35,402
Loading xslF345X05/ownership.xml…